World's Best Scientists 2026 revealed!
Reinhard Schneppenheim

Reinhard Schneppenheim

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
17383
World Ranking
7760
National Ranking
568

Reinhard Schneppenheim publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Reinhard Schneppenheim sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 274 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Reinhard Schneppenheim D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Reinhard Schneppenheim sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 68 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Reinhard Schneppenheim is affiliated with Universität Hamburg in Germany and conducts research primarily within the field of Medicine, with a focus on Hematology. Their work covers several significant subfields including Genetics, Immunology, Surgery, and Pulmonary and Respiratory Medicine.

Their research topics encompass a variety of areas related to blood and coagulation disorders, such as Platelet Disorders and Treatments, Blood groups and transfusion, Complement system in diseases, Blood properties and coagulation, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Heparin-Induced Thrombocytopenia and Thrombosis, and other Blood disorders and treatments.

Schneppenheim has contributed to multiple publications in venues commonly associated with hematology and blood research. Frequent publication venues include:

  • Hämostaseologie
  • Journal of Thrombosis and Haemostasis
  • Blood
  • Research Square (Research Square)
  • Blood Advances

Their recent publications illustrate a focus on complex blood-related diseases and their genetic and clinical risk factors. Selected recent papers are:

  • Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study (2020), Journal of Thrombosis and Haemostasis
  • Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK) (2020), European Journal of Cancer
  • Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS (2021), Blood Advances
  • Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF (2020), BMC Molecular and Cell Biology
  • von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS (2023), Journal of Thrombosis and Haemostasis

Throughout their research career, Schneppenheim has frequently collaborated with fellow researchers, with notable co-authors including Tobias Obser, Paul Knöbl, Masanori Matsumoto, Bernhard Lämmle, and Ulrich Budde. These collaborations have often intersected in producing work on blood disorders and coagulation.

Best Publications

  • Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

    J E Sadler;U Budde;J C J Eikenboom;E J Favaloro

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11

    Udo zur Stadt;Susanne Schmidt;Brigitte Kasper;Karin Beutel

  • A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)

    A Tosetto;F Rodeghiero;G Castaman;A Goodeve

  • Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand Disease (MCMDM-1VWD)

    Anne C. Goodeve;Jeroen Eikenboom;Giancarlo Castaman;Francesco Rodeghiero

  • Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

    Pascal D. Johann;Pascal D. Johann;Serap Erkek;Marc Zapatka;Kornelius Kerl

  • Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

    Reinhard Schneppenheim;Michael C. Frühwald;Stefan Gesk;Martin Hasselblatt

  • Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.

    René Santer;Reinhard Schneppenheim;Anja Dombrowski;Hermann Götze

  • Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A.

    Udo Zur Stadt;Karin Beutel;Susanne Kolberg;Reinhard Schneppenheim

  • von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

    Reinhard Schneppenheim;Ulrich Budde;Florian Oyen;Dorothea Angerhaus

  • Childhood cancer predisposition syndromes : A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

    Tim Ripperger;Stefan S. Bielack;Arndt Borkhardt;Ines B. Brecht;Ines B. Brecht

  • Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression

    Martin Hasselblatt;Stefan Gesk;Florian Oyen;Sabrina Rossi

  • Haemophilia A: from mutation analysis to new therapies

    Jochen Graw;Hans-Hermann Brackmann;Johannes Oldenburg;Reinhard Schneppenheim

  • Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD) : results from the European Study MCMDM-1VWD

    Giancarlo Castaman;Stefan Lethagen;Augusto B. Federici;Alberto Tosetto

  • Recombinant ADAMTS-13: First-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

    Marie Scully;Paul Knöbl;Karim Kentouche;Lawrence Rice

  • Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.

    Marcus Stockschlaeder;Reinhard Schneppenheim;Ulrich Budde

  • Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism.

    U. Nowak‐Göttl;H. G. Koch;I. Aschka;B. Kohlhase

  • Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    U Budde;R Schneppenheim;J Eikenboom;A Goodeve

  • Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

    Sandra L. Haberichter;Sandra L. Haberichter;Sandra L. Haberichter;Giancarlo Castaman;Ulrich Budde;Ian Peake

  • Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts

    Tobias Lange;Christoph Stehling;Birgit Fröhlich;Mark Klingenhöfer

Frequent Co-Authors

Reiner Siebert
Reiner Siebert University of Ulm
Marcel Kool
Marcel Kool German Cancer Research Center
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Johannes Oldenburg
Johannes Oldenburg University of Bonn
David Capper
David Capper Charité - University Medicine Berlin
Francesco Rodeghiero
Francesco Rodeghiero Yamagata University
Werner Paulus
Werner Paulus University of Münster
Norbert Graf
Norbert Graf Saarland University
Lars Holmberg
Lars Holmberg King's College London
Ulrich Schüller
Ulrich Schüller Universität Hamburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens doors to many health-related fields beyond the lab. One popular pathway is medical coding, a vital role in healthcare administration. The medical.coding salary remains competitive, and the field offers stable job opportunities due to ongoing demand for skilled coders.

If you’re considering medical billing and coding, it’s helpful to understand both the rewards and challenges of the career. Read more about is medical billing and coding in demand to see if this growing field suits your goals.

For those interested in healthcare management, earning an online health information management degree can lead to roles that blend science, technology, and leadership. These programs are ideal for students seeking flexible ways to advance their careers.

Alternatively, a passion for biochemistry or health can lead to nutrition science. Check out online degrees in nutrition for affordable master’s options that can help you become a food and wellness expert.

Best Scientists Citing Reinhard Schneppenheim

Trending Scientists

Recently Published Articles